Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • أخبار باللغة العربية
  • +971 (0) 4 368 1644
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • Telephone

      • +971 (0) 4 368 1644 from 8 AM - 5:30 PM GMT

      • Contact
      • Contact

        +971 (0) 4 368 1644
        from 8 AM - 5:30 PM GMT

    Close menu
  • News
  • Products
  • Contact
    • Request More Information
    • Client Login
    • Send a Release
    • 2 News in Focus
    • 5 Business & Money
    • 5 Science & Tech
    • 5 Lifestyle & Health
    • 1 Policy & Public Interest
    • 1 People & Culture
    • Request More Information
    • Client Login
    • Send a Release
    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • Request More Information
    • Client Login
    • Send a Release
    • General Inquiries
    • Worldwide Offices
    • Request More Information
    • Client Login
    • Send a Release
    Close submenu (News in Focus) News in Focus
    • Browse News Releases
    • Multimedia Gallery
    Close submenu (Business & Money) Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
    Close submenu (Science & Tech) Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
    Close submenu (Lifestyle & Health) Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
    Close submenu (Policy & Public Interest) Policy & Public Interest
    • Policy & Public Interest
    Close submenu (People & Culture) People & Culture
    • People & Culture

    Docquity Extends Asian Healthcare Intelligence to Japan Through Deepened Strategic Partnership with exMedio

    • APAC - English
    • Japan - Japanese
    • Middle East - Arabic
    Docquity

    News provided by

    Docquity

    06 Oct, 2026, 03:58 GMT

    Share this article

    Share this article


    Japan scale up advances Docquity's goal of Asian Healthcare Intelligence built on Clinical Intent, with Ask Dx as the core platform and "One Asia" linking physicians in Japan and Southeast Asia

    SINGAPORE, Oct. 6, 2026 /PRNewswire/ -- Docquity, the clinical AI platform for more than 75% of verified doctors across Asia, today announced its scale up plan into Japan through a deepened strategic partnership with exMedio Inc., operator of the specialist physician communities Hematology Pro and Hipokura.

    The move advances Docquity's goal of building Asian Healthcare Intelligence, grounded in Clinical Intent: what doctors across Asia need answered at the point of care.

    DOCQUITY HOLDINGS PTE. LTD. and Docquity Japan G.K. have signed a memorandum of understanding (MOU) with exMedio that places Ask Dx, Docquity's clinical AI assistant, at the core of the partnership. The MOU builds on a collaboration that began in 2025, when Docquity first offered Ask Dx to members of Hipokura, exMedio's clinical consultation community of more than 80,000 physicians. The relationship now moves from supplying an AI tool to building clinical support for Japanese physicians together, and to connecting physician communities in Japan and Southeast Asia.

    Asian Healthcare Intelligence, built on Clinical Intent

    Docquity's goal is an intelligence layer for healthcare in Asia, built from how doctors in the region practice. Its starting point is Clinical Intent: what a doctor is trying to resolve at the point of care, expressed in the questions they ask, the knowledge they look for and the peer discussions that interest them.

    Ask Dx answers that intent for each doctor. Understood across markets and specialties, Clinical Intent shows where knowledge needs are greatest, so that medical education and clinical support can be directed to them.

    Japan, with its established specialist physician communities, is one of Docquity's core markets in that effort.

    Entering Japan with a specialist medical partner

    Docquity is entering Japan through the communities' Japanese physicians already use. exMedio launched Hematology Pro in 2022, and more than 60% of Japan's hematologists are now members, making it one of the country's largest specialist communities. exMedio plans to extend that model from hematologic cancers to solid tumors.

    The partnership pairs exMedio's specialist network and understanding of Japanese clinical practice with Docquity's clinical AI and its physician network across Asia. It will concentrate on knowledge sharing and clinical support in oncology, and services will be developed with feedback from physicians in Japan.

    Ask Dx as the core platform

    Ask Dx is the core platform of the partnership. It will be built into the places where physicians in exMedio's communities learn, consult peers and search for medical information, so that it works inside their daily clinical routines.

    Combining Ask Dx with the experiential knowledge held in specialist communities is intended to give physicians fast, context-relevant access to the knowledge they need.

    Specific services, features and launch timing will be announced separately.

    One Asia: connecting Japan and Southeast Asia

    One Asia is Docquity's vision for putting the knowledge and experience held in physician communities to use across borders. It connects the physician communities on which Asian Healthcare Intelligence is built. Under the MOU, Docquity and exMedio will explore exchange and knowledge sharing between physician communities in Japan and Southeast Asia.

    Physicians across Asia share a challenge: keeping up with growing medical knowledge and applying it within different healthcare systems and practice settings. The partnership aims to create more opportunities for communities to exchange knowledge on shared clinical challenges, while respecting differences in language, healthcare systems and practice environments.

    Over time, the companies will consider wider collaboration that includes universities and medical institutions.

    Executive comments

    Indranil Roychowdhury

    CEO and Co-Founder, Docquity

    "Our goal is Asian Healthcare Intelligence: clinical AI that understands what doctors in Asia are asking and helps them act on it. That starts with Clinical Intent, and Japan is central to it.

    exMedio has built specialist communities that physicians in Japan rely on, and its understanding of clinical practice there is the foundation of this partnership. With Ask Dx at the core, we will work with exMedio to help physicians in Japan and Southeast Asia reach the knowledge they need faster and learn from one another across borders."

    Keiji Sawada

    Representative Director, President and Executive Officer, exMedio Inc.

    "This MOU moves our relationship with Docquity from adopting an AI service to a stage where we combine our strengths to co-create new clinical support.

    Going forward, we will extend the expertise we have built in hematology to solid tumors and, by combining it with Docquity's AI technology and Asian physician network, build a clinical support environment that gives physicians faster access to the knowledge they need."

    About Docquity

    Docquity is building Asian Healthcare Intelligence: clinical AI and insight grounded in Clinical Intent, what doctors need answered at the point of care. It is the clinical AI thinking partner for more than 500,000 verified doctors across Southeast Asia, Japan and the GCC. Its clinical AI assistant, Ask Dx, helps doctors access medical knowledge and apply it in daily clinical practice. Docquity also provides digital services that support connections between physicians, learning and clinical activity. The company is headquartered in Singapore.

    About exMedio

    exMedio is a Japanese medical technology company that develops healthcare support software and digital services. It operates Hipokura, a clinical consultation community connecting more than 80,000 physicians; the specialist community Hematology Pro; and "Migiude-kun," a subscription practice-support service for medical institutions. By supporting doctor-to-doctor case consultation, sharing of experiential knowledge and continuous learning, exMedio works to create an environment where physicians can learn from and help one another to raise their clinical expertise.

    Modal title

    Also from this source

    Docquity Extends Asian Healthcare Intelligence to the Middle East Through Strategic Partnership with Growth Partner Holding

    Docquity Extends Asian Healthcare Intelligence to the Middle East Through Strategic Partnership with Growth Partner Holding

    Docquity, the clinical AI platform for more than 500,000 verified doctors across Asia, today announced a strategic partnership with Growth Partner...

    Growth Partner and Docquity Launch Landmark Medically Supervised and Technology-Enabled Umrah Program

    Growth Partner and Docquity Launch Landmark Medically Supervised and Technology-Enabled Umrah Program

    Growth Partner and Docquity today announced the launch of the world's first medically supervised, technology-enabled Umrah programme, working...

    More Releases From This Source

    Explore

    Medical Pharmaceuticals

    Medical Pharmaceuticals

    Health Care & Hospitals

    Health Care & Hospitals

    Pharmaceuticals

    Pharmaceuticals

    Artificial Intelligence

    Artificial Intelligence

    News Releases in Similar Topics

    Contact PR Newswire

    • +971 (0) 4 368 1644
      from 8 AM - 5:30 PM GMT

    Global Sites

    • APAC
    • APAC - Traditional Chinese
    • Asia
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany

     

    • India
    • Indonesia
    • Israel
    • Italy
    • Mexico
    • Middle East
    • Middle East - Arabic
    • Netherlands
    • Norway
    • Poland

     

    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom
    • United States

    Do not sell or share my personal information:

    • Submit via [email protected] 
    • Call Privacy toll-free: 877-297-8921
    Global Sites
    • Asia
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany
    • India
    • Israel
    • Italy
    • Mexico
    • Middle East
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom
    • United States
    +971 (0) 4 368 1644
    from 8 AM - 5:30 PM GMT
    • Terms of Use
    • Privacy Policy
    • GDPR
    • Information Security Policy
    • Site Map
    • Cookie Settings
    Copyright © 2026 Cision US Inc.